STOCK TITAN

Shattuck Labs: Deep Track reports 4.92% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Shattuck Labs, Inc. (STTK) reported that Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin each beneficially owned 5,000,033 shares, or 4.92%, as of September 30, 2026, with shared voting and dispositive power.

The reported amount includes 1,293,299 pre-funded warrants exercisable for common stock. Exercise is limited when it would cause the holders’ collective beneficial ownership to exceed 9.99% of common stock outstanding after exercise. The percentage calculation used 100,363,253 common shares outstanding as of August 7, 2026, plus the warrants, for a stated denominator of 101,656,552 shares.

Beneficial ownership 5,000,033 shares Each reporting person reported the same shared position as of September 30, 2026.
Ownership percentage 4.92% Reported for each reporting person as of September 30, 2026.
Pre-funded warrants 1,293,299 warrants Included in the reported beneficial ownership amount; exercisable for common stock subject to a 9.99% maximum ownership limitation.
Maximum Percentage 9.99% Exercise limitation for the pre-funded warrants.
Shares used in ownership calculation 101,656,552 shares Stated denominator, including the warrant shares used in the calculation.
Common shares outstanding 100,363,253 shares Outstanding as of August 7, 2026, according to the ownership calculation.
beneficially owned technical
"Amount beneficially owned by each Reporting Person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Pre-Funded Warrants technical
"The beneficially owned shares include 1,293,299 Pre-Funded Warrants"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Maximum Percentage technical
"the "Maximum Percentage" of the number of Common Stock outstanding"
Shared Dispositive Power technical
"Shared Dispositive Power 5,000,033.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many STTK shares did Deep Track and David Kroin report owning?

The three reporting persons each reported beneficial ownership of 5,000,033 shares, or 4.92%, as of September 30, 2026. The amounts represent the same shared position, not separate holdings to add together.

What limit applies to exercise of the STTK pre-funded warrants?

The 1,293,299 pre-funded warrants are subject to a 9.99% maximum ownership limit: exercise is restricted to the extent it would cause the holders’ collective beneficial ownership to exceed that percentage of common stock outstanding after exercise.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





82024L103

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Deep Track Capital, LP
Signature:/s/ David Kroin
Name/Title:David Kroin, Managing Member of the General Partner of the Investment Adviser
Date:11/16/2026
Deep Track Biotechnology Master Fund, Ltd.
Signature:/s/ David Kroin
Name/Title:David Kroin, Director
Date:11/16/2026
David Kroin
Signature:/s/ David Kroin
Name/Title:David Kroin
Date:11/16/2026
Exhibit Information

Item 4: Information with respect to the Reporting Persons' ownership of the Common Stock as of September 30, 2026, is incorporated by reference to items (5) - (9) and (11) of the cover page of the respective Reporting Person. The amount beneficially owned by each Reporting Person is determined using 101,656,552 shares, calculated using 100,363,253 Common Stock outstanding as of August 7, 2026, according to the issuer's 10-Q filed with the SEC on August 11, 2026 and 1,293,299 Pre-Funded Warrants that would be converted to Common Stock by the Reporting Person up to the Maximum Percentage. The beneficially owned shares include 1,293,299 Pre-Funded Warrants exercisable to common shares, subject to a 9.99% Maximum Percentage exercise limitation. The Issuer shall not effect the exercise of any portion of the Pre-Funded Warrants, to the extent that after giving effect to such exercise, the holder collectively would beneficially own in excess of 9.99% (the "Maximum Percentage") of the number of Common Stock outstanding immediately after giving effect to such exercise. JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. Dated: November 16, 2026 Deep Track Capital, LP By: /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser Deep Track Biotechnology Master Fund, Ltd. By: /s/ David Kroin David Kroin, Director David Kroin By: /s/ David Kroin David Kroin

Keep reading